335 related articles for article (PubMed ID: 16569736)
1. PRKAR1A Mutations and protein kinase A interactions with other signaling pathways in the adrenal cortex.
Robinson-White A; Meoli E; Stergiopoulos S; Horvath A; Boikos S; Bossis I; Stratakis CA
J Clin Endocrinol Metab; 2006 Jun; 91(6):2380-8. PubMed ID: 16569736
[TBL] [Abstract][Full Text] [Related]
2. 17q22-24 chromosomal losses and alterations of protein kinase a subunit expression and activity in adrenocorticotropin-independent macronodular adrenal hyperplasia.
Bourdeau I; Matyakhina L; Stergiopoulos SG; Sandrini F; Boikos S; Stratakis CA
J Clin Endocrinol Metab; 2006 Sep; 91(9):3626-32. PubMed ID: 16772351
[TBL] [Abstract][Full Text] [Related]
3. Protein kinase-A activity in PRKAR1A-mutant cells, and regulation of mitogen-activated protein kinases ERK1/2.
Robinson-White A; Hundley TR; Shiferaw M; Bertherat J; Sandrini F; Stratakis CA
Hum Mol Genet; 2003 Jul; 12(13):1475-84. PubMed ID: 12812976
[TBL] [Abstract][Full Text] [Related]
4. Molecular and functional analysis of PRKAR1A and its locus (17q22-24) in sporadic adrenocortical tumors: 17q losses, somatic mutations, and protein kinase A expression and activity.
Bertherat J; Groussin L; Sandrini F; Matyakhina L; Bei T; Stergiopoulos S; Papageorgiou T; Bourdeau I; Kirschner LS; Vincent-Dejean C; Perlemoine K; Gicquel C; Bertagna X; Stratakis CA
Cancer Res; 2003 Sep; 63(17):5308-19. PubMed ID: 14500362
[TBL] [Abstract][Full Text] [Related]
5. Inactivation of the Carney complex gene 1 (protein kinase A regulatory subunit 1A) inhibits SMAD3 expression and TGF beta-stimulated apoptosis in adrenocortical cells.
Ragazzon B; Cazabat L; Rizk-Rabin M; Assie G; Groussin L; Fierrard H; Perlemoine K; Martinez A; Bertherat J
Cancer Res; 2009 Sep; 69(18):7278-84. PubMed ID: 19738044
[TBL] [Abstract][Full Text] [Related]
6. Molecular cloning, chromosomal localization of human peripheral-type benzodiazepine receptor and PKA regulatory subunit type 1A (PRKAR1A)-associated protein PAP7, and studies in PRKAR1A mutant cells and tissues.
Liu J; Matyakhina L; Han Z; Sandrini F; Bei T; Stratakis CA; Papadopoulos V
FASEB J; 2003 Jun; 17(9):1189-91. PubMed ID: 12692076
[TBL] [Abstract][Full Text] [Related]
7. A transgenic mouse bearing an antisense construct of regulatory subunit type 1A of protein kinase A develops endocrine and other tumours: comparison with Carney complex and other PRKAR1A induced lesions.
Griffin KJ; Kirschner LS; Matyakhina L; Stergiopoulos SG; Robinson-White A; Lenherr SM; Weinberg FD; Claflin ES; Batista D; Bourdeau I; Voutetakis A; Sandrini F; Meoli EM; Bauer AJ; Cho-Chung YS; Bornstein SR; Carney JA; Stratakis CA
J Med Genet; 2004 Dec; 41(12):923-31. PubMed ID: 15591278
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase A subunit expression is altered in Bloom syndrome fibroblasts and the BLM protein is increased in adrenocortical hyperplasias: inverse findings for BLM and PRKAR1A.
Heyerdahl SL; Boikos S; Horvath A; Giatzakis C; Bossis I; Stratakis CA
Horm Metab Res; 2008 Jun; 40(6):391-7. PubMed ID: 18401830
[TBL] [Abstract][Full Text] [Related]
9. Depletion of type IA regulatory subunit (RIalpha) of protein kinase A (PKA) in mammalian cells and tissues activates mTOR and causes autophagic deficiency.
Mavrakis M; Lippincott-Schwartz J; Stratakis CA; Bossis I
Hum Mol Genet; 2006 Oct; 15(19):2962-71. PubMed ID: 16963469
[TBL] [Abstract][Full Text] [Related]
10. Activation of cyclic AMP signaling leads to different pathway alterations in lesions of the adrenal cortex caused by germline PRKAR1A defects versus those due to somatic GNAS mutations.
Almeida MQ; Azevedo MF; Xekouki P; Bimpaki EI; Horvath A; Collins MT; Karaviti LP; Jeha GS; Bhattacharyya N; Cheadle C; Watkins T; Bourdeau I; Nesterova M; Stratakis CA
J Clin Endocrinol Metab; 2012 Apr; 97(4):E687-93. PubMed ID: 22259056
[TBL] [Abstract][Full Text] [Related]
11. Primary pigmented nodular adrenocortical disease reveals insulin-like growth factor binding protein-2 regulation by protein kinase A.
Shi Z; Henwood MJ; Bannerman P; Batista D; Horvath A; Guttenberg M; Stratakis CA; Grimberg A
Growth Horm IGF Res; 2007 Apr; 17(2):113-21. PubMed ID: 17280861
[TBL] [Abstract][Full Text] [Related]
12. Protein kinase A alterations in endocrine tumors.
Yu B; Ragazzon B; Rizk-Rabin M; Bertherat J
Horm Metab Res; 2012 Sep; 44(10):741-8. PubMed ID: 22752956
[TBL] [Abstract][Full Text] [Related]
13. Mutational analysis of PRKAR1A and Gs(alpha) in sporadic adrenocortical tumors.
Libé R; Mantovani G; Bondioni S; Lania AG; Pedroni C; Beck-Peccoz P; Spada A
Exp Clin Endocrinol Diabetes; 2005 May; 113(5):248-51. PubMed ID: 15926108
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of the cyclic AMP-dependent protein kinase A (PKA) regulatory subunit 1A (PRKAR1A) gene in patients with Carney complex and primary pigmented nodular adrenocortical disease (PPNAD) reveals novel mutations and clues for pathophysiology: augmented PKA signaling is associated with adrenal tumorigenesis in PPNAD.
Groussin L; Kirschner LS; Vincent-Dejean C; Perlemoine K; Jullian E; Delemer B; Zacharieva S; Pignatelli D; Carney JA; Luton JP; Bertagna X; Stratakis CA; Bertherat J
Am J Hum Genet; 2002 Dec; 71(6):1433-42. PubMed ID: 12424709
[TBL] [Abstract][Full Text] [Related]
15. PRKAR1A inactivation leads to increased proliferation and decreased apoptosis in human B lymphocytes.
Robinson-White AJ; Leitner WW; Aleem E; Kaldis P; Bossis I; Stratakis CA
Cancer Res; 2006 Nov; 66(21):10603-12. PubMed ID: 17079485
[TBL] [Abstract][Full Text] [Related]
16. Mutations of the gene encoding the protein kinase A type I-alpha regulatory subunit (PRKAR1A) in patients with the "complex of spotty skin pigmentation, myxomas, endocrine overactivity, and schwannomas" (Carney complex).
Stratakis CA
Ann N Y Acad Sci; 2002 Jun; 968():3-21. PubMed ID: 12119264
[TBL] [Abstract][Full Text] [Related]
17. In vitro functional studies of naturally occurring pathogenic PRKAR1A mutations that are not subject to nonsense mRNA decay.
Greene EL; Horvath AD; Nesterova M; Giatzakis C; Bossis I; Stratakis CA
Hum Mutat; 2008 May; 29(5):633-9. PubMed ID: 18241045
[TBL] [Abstract][Full Text] [Related]
18. Regulatory subunit type I-alpha of protein kinase A (PRKAR1A): a tumor-suppressor gene for sporadic thyroid cancer.
Sandrini F; Matyakhina L; Sarlis NJ; Kirschner LS; Farmakidis C; Gimm O; Stratakis CA
Genes Chromosomes Cancer; 2002 Oct; 35(2):182-92. PubMed ID: 12203783
[TBL] [Abstract][Full Text] [Related]
19. Wnt/beta-catenin and 3',5'-cyclic adenosine 5'-monophosphate/protein kinase A signaling pathways alterations and somatic beta-catenin gene mutations in the progression of adrenocortical tumors.
Gaujoux S; Tissier F; Groussin L; Libé R; Ragazzon B; Launay P; Audebourg A; Dousset B; Bertagna X; Bertherat J
J Clin Endocrinol Metab; 2008 Oct; 93(10):4135-40. PubMed ID: 18647815
[TBL] [Abstract][Full Text] [Related]
20. The regulatory 1α subunit of protein kinase A modulates renal cystogenesis.
Ye H; Wang X; Constans MM; Sussman CR; Chebib FT; Irazabal MV; Young WF; Harris PC; Kirschner LS; Torres VE
Am J Physiol Renal Physiol; 2017 Sep; 313(3):F677-F686. PubMed ID: 28615245
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
